Key result
Cardiomyocyte-specific HSPB1 deficiency increased MI-induced cardiac rupture, mortality, and adverse remodelling compared with wild-type controls within 21 days after MI.
Why the study?
Does cardiomyocyte-specific HSPB1 deficiency worsen cardiac dysfunction and inflammation after myocardial infarction in mice?
Does cardiomyocyte-specific HSPB1 deficiency worsen cardiac dysfunction and inflammation after myocardial infarction in mice?
Cardiomyocyte HSPB1 acts as a critical negative regulator of NFκB-mediated inflammation and is required for proper wound healing and prevention of cardiac rupture after myocardial infarction.
Answers are grounded in this paper and cite their sources.
HSPB1 deficiency worsens post-MI outcomes in mice; extends mechanistic insights into healing but leaves open clinical translation.
Aims: Inadequate healing after myocardial infarction (MI) leads to heart failure and fatal ventricular rupture, while optimal healing requires timely induction and resolution of inflammation. This study tested the hypothesis that heat shock protein B1 (HSPB1), which limits myocardial inflammation during endotoxemia, modulates wound healing after MI. Methods and results: To test this hypothesis, cardiomyocyte-specific HSPB1 knockout (Hspb1-/-) mice were generated using the Cre-LoxP recombination system. MI was induced by ligation of the left anterior descending coronary artery in Hspb1-/- and wild-type (WT) littermates. HSPB1 was up-regulated in cardiomyocytes of WT animals in response to MI, and deficiency of cardiomyocyte HSPB1 increased MI-induced cardiac rupture and mortality within 21 days after MI. Serial echocardiography showed more aggravated remodelling and cardiac dysfunction in Hspb1-/- mice than in WT mice at 1, 3, and 7 days after MI. Decreased collagen deposition and angiogenesis, as well as increased MMP2 and MMP9 activity, were also observed in Hspb1-/- mice compared with WT controls after MI, using immunofluorescence, polarized light microscopy, and zymographic analyses. Notably, Hspb1-/- hearts exhibited enhanced and prolonged leucocyte infiltration, enhanced expression of inflammatory cytokines, and enhanced TLR4/MyD88/NFκB activation compared with WT controls after MI. In-depth molecular analyses in both mice and primary cardiomyocytes demonstrated that cardiomyocyte-specific knockout of HSPB1 increased nuclear factor-κB (NFκB) activation, which promoted the expression of proinflammatory mediators. This led to increased leucocyte recruitment, thereby to excessive inflammation, ultimately resulting in adverse remodelling, cardiac dysfunction, and cardiac rupture following MI. Conclusion: These data suggest that HSPB1 acts as a negative regulator of NFκB-mediated leucocyte recruitment and the subsequent inflammation in cardiomyocytes. Cardiomyocyte HSPB1 is required for wound healing after MI and could be a target for myocardial repair in MI patients.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) studied Myocardial infarction. Cardiomyocyte-specific HSPB1 deficiency vs. Wild-type (WT) littermates was evaluated on Cardiac rupture and mortality. Cardiomyocyte-specific HSPB1 deficiency increased MI-induced cardiac rupture, mortality, and adverse remodelling compared with wild-type controls within 21 days after MI.
Synapse has enriched 10 related papers. Consider them for comparative context: